Optimizing GLP-1 therapies for obesity and diabetes management
Maximizing the benefits of GLP-1 therapies require a multidisciplinary approach that integrates evidence-based nutrition, physical activity, and proactive management of gastrointestinal side effects. Such an approach can enhance adherence, preserve functional capacity, and sustain the long-term benefits of these therapies.
Authors
- John L. Sievenpiper (ORCID: https://orcid.org/0000-0002-3270-5772)
- Laura Chiavaroli (ORCID: https://orcid.org/0000-0002-8900-6366)
- Ian J. Neeland (ORCID: https://orcid.org/0000-0003-2831-3618)
- Andreas F. H. Pfeiffer (ORCID: https://orcid.org/0000-0002-6887-0016)
- Jarvis C. Noronha
- Angela Fitch (ORCID: https://orcid.org/0000-0001-9912-5994)
- Cyril W.C. Kendall
- Luc F. Van Gaal
Institutions
- St. Michael's Hospital (CA)
- University of Antwerp (BE)
- The University of Queensland (AU)
- University of Toronto (CA)
- University Hospitals of Cleveland (US)
- Helmholtz Zentrum München (DE)
- University of Saskatchewan (CA)
- Know Center Research GmbH (Austria) (AT)
- Antwerp University Hospital (BE)
- University School (US)
- German Center for Diabetes Research (DE)
- Franklin University (US)
- Case Western Reserve University (US)
Publication Details
- Journal
- Obesity Pillars
- Published
- 2025-10-25
- DOI
- https://doi.org/10.1016/j.obpill.2025.100222
- Citations
- 1
- Primary Topic
- Diet and metabolism studies
- Type
- article
- Field-Weighted Citation Impact
- 1.16